Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 11
Submit an article Journal homepage
83
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

CD20 expression by Hodgkin–Reed–Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients

Vera Aldred Faculty of Medicine, Department of Pathology, Clinics Hospital, University of São Paulo, Brazil
,
José Vassallo Laboratory of Investigative and Molecular Pathology, CIPED, State University of Campinas Medical School (Unicamp), SP, Brazil; Post-graduation Program, Hospital do Câncer de São Paulo, Fundação Antonio Prudente, Brazil
,
Antônio Hugo J. Froes M. Campos Department of Pathology, Hospital do Câncer de São Paulo, Fundação Antonio Prudente, São Paulo, Brazil
&
Fernando Augusto Soares Department of Pathology, University of São Paulo, São PauloBrazil; Department of Pathology, Hospital do Câncer de São Paulo, Fundação Antonio Prudente, São Paulo, BrazilCorrespondence[email protected]
Pages 2198-2202 | Received 15 May 2008, Accepted 30 May 2008, Published online: 01 Jul 2009

References

  • Isaacson P G, Ashton-Key M. Phenotype of Hodgkin's and Reed–Sternberg cells. Lancet 1996; 347–481
  • Lauritzen A F, Moller P H, Nedergaard T, Guldberg P, Hou-Jensen K, Ralfkiaer E. Apoptosis-related genes and proteins in Hodgkin's disease. APMIS 1999; 107: 636–644
  • Vassallo J, Metze K, Traina F, Souza C A, Loran-Metze I. Further remarks on the expression of CD20 in classical Hodgkin's lymphomas. Haematologica 2002; 87: ELT17
  • Von Wasielewski R, Mengel M, Fisher R, Hansmann M L, Hübner K, Franklin J, et al. Classical Hodgkin's disease. Clinical impact of the immunophenotype. Am J Pathol 1997; 151: 1123–1130
  • Tzarkov A, Zimpfer A, Pehrs A C, Lugli A, Went P, Mauer R, et al. Expression of B-cell markers in classical Hodgkin lymphoma: a tissue microarray analysis of 330 cases. Mod Pathol 2003; 16: 1141–1147
  • Portlock C S, Donnelly G B, Qin J, Straus D, Yahalom J, Zelenetz A, et al. Adverse prognostic significance of CD20 positive Reed–Sternberg cells in classical Hodgkin's disease. Br J Haematol 2004; 125: 701–708
  • Rassidakis G Z, Medeiros L J, Viviani S, Bonfante V, Nadali G P, Vassilakopoulos T P, et al. CD20 expression in Hodgkin and Reed–Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. J Clin Oncol 2002; 20: 1278–1287
  • Tzankov A, Krugmann J, Fend F, Fishhofer M, Greil R, Dirnhofer S. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases. Clin Cancer Res 2003; 9: 1381–1386
  • Younes A, Romaguera J, Hagemeister F, McLaughlin P, Rodriguez M A, Fiumara P, et al. A pilot study of rituximab in patients with recurrent classic Hodgkin disease. Cancer 2003; 98: 310–314
  • Kirchner E M, Ebsen M, Kirchner J, Theegarten D, Voigtmann R. Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after rituximab monotherapy. Ann Oncol 2001; 12: 1169–1171
  • Rehwald U, Schulz H, Reiser M, Sieber M, Staak J O, Morschhauser F, et al. Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Blood 2003; 101: 420–424
  • Al-Ali H K, Wittekind C, Niederwieser D. Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab. Dtsch Med Wochenschr 2007; 132: 1688–1691
  • Bai M C, Jiwa N M, Horstman A, Vos W, Kluin P H, Van Der Valk P, et al. Decreased expression of cellular markers in Epstein–Barr virus positive Hodgkin's disease. J Pathol 1994; 174: 49–55
  • Keegan T HMK, Glaser S L, Clarke C A, Gulley M L, Craig F E, DiGiuseppe J A, et al. Epstein–Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol 2005; 23: 7604–7613

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.